Ligand Pharmaceuticals | Creditori Commerciali

Prezzo Delle Azioni
185.60
Cambio Giornaliero
-1.33 -0.71%
Mensile
-10.26%
Annuale
64.58%
Q1 Previsione
184.59




Creditori Commerciali Cambiamento Data
Agenus USD 85.29M 10.89M 2025-09
Amgen USD 20.89B 1.25B 2025-12
Anika Therapeutics USD 4.73M 39K 2025-09
Arrowhead Research USD 32.94M 15.26M 2025-12
Baxter International USD 953M 42M 2025-09
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Eli Lilly USD 4.26B 186.5M 2025-09
Enanta Pharmaceuticals USD 1.95M 1.6M 2025-09
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Glaxosmithkline GBP 21.07B 7.42B 2025-09
Heron Therapeutics USD 12.02M 20K 2025-09
Insmed USD 79.59M 1.24M 2025-09
Intrexon USD 4.85M 3.12M 2024-06
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
Ligand Pharmaceuticals USD 27.76M 1.72M 2025-09
MacroGenics USD 5.94M 1.28M 2025-09
Merck USD 4.15B 102M 2025-09
Pacira USD 17.69M 12.44M 2025-09
Pfizer USD 5.02B 142M 2025-09
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Veracyte USD 5.51M 5.94M 2025-09


Ligand Pharmaceuticals Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.